Autonomic Nervous System Drugs Practice Questions

Q: All of the following drugs cause mydriasis except?

Pilocarpine. **Explanation:** To understand mydriasis (pupillary dilation), one must distinguish between the two muscles of the iris: the **Dilator Pupillae** (Sympathetic control via $\alpha_1$ receptors) and the **Sphincter Pupillae** (Parasympathetic control via $M_3$ receptors). **Why Pilocarpine is the correct answer:** Pilocarpine is a **direct-acting cholinergic agonist**. It stimulates the $M_3$ muscarinic receptors on the Sphincter Pupillae, causing it to contract. This results in **miosis** (pupillary constriction), not mydriasis. It also causes contraction of the ciliary muscle, leading to accommodation for near vision and decreased intraocular pressure, making it useful in glaucoma. **Analysis of incorrect options:** * **Phenylephrine:** A selective $\alpha_1$ agonist. It stimulates the Dilator Pupillae directly, causing **active mydriasis** without affecting accommodation (no cycloplegia). * **Epinephrine:** A non-selective adrenergic agonist. It acts on $\alpha_1$ receptors to cause mydriasis. It is often used in intraocular surgeries to maintain pupillary dilation. * **Atropine:** An anticholinergic (muscarinic antagonist). By blocking $M_3$ receptors on the Sphincter Pupillae, it allows the dilator muscle to dominate, resulting in **passive mydriasis**. It also causes **cycloplegia** (paralysis of accommodation). **High-Yield Clinical Pearls for NEET-PG:** 1. **Active vs. Passive Mydriasis:** Sympathomimetics (Phenylephrine) cause active mydriasis; Parasympatholytics (Atropine) cause passive mydriasis. 2. **Drug of choice for Fundus examination:** Tropicamide (fastest onset, shortest duration). 3. **Phenylephrine** is preferred when you want to dilate the pupil without blurring the patient's vision (as it spares the ciliary muscle). 4. **Miosis Mnemonic:** "Point" (Parasympathetic/Pilocarpine = Pinpoint/Miosis); "Dilation" (Sympathetic = Dilation).

Q: Which of the following is an example of antisialogogues used to control moisture during orthodontic bonding?

Banthine. **Explanation:** The correct answer is **Banthine (Methantheline bromide)**. **1. Why Banthine is correct:** Banthine is a synthetic **antimuscarinic (anticholinergic)** agent. In dentistry and orthodontics, it is used as an **antisialogogue**—a drug that reduces the flow of saliva. During orthodontic bonding, maintaining a dry field is critical for the bond strength of resins. Banthine works by competitively inhibiting M3 muscarinic receptors on salivary glands, thereby blocking parasympathetic stimulation and significantly decreasing salivary secretions. **2. Analysis of Incorrect Options:** * **A. Epinephrine:** A sympathomimetic (alpha and beta agonist). While it causes vasoconstriction (often used with local anesthetics to reduce bleeding), it does not effectively suppress salivary gland secretion for bonding procedures. * **B. Betamethasone dipropionate:** A potent topical corticosteroid used for inflammatory skin conditions or oral mucosal lesions (like lichen planus). It has no effect on salivary flow. * **C. Paracetamol:** A non-opioid analgesic and antipyretic. It inhibits prostaglandin synthesis in the CNS but lacks anticholinergic properties. **3. NEET-PG High-Yield Pearls:** * **Propantheline (Pro-Banthine)** is a related quaternary ammonium compound often used similarly to Methantheline. * **Contraindications:** Antisialogogues (anticholinergics) should be avoided in patients with **Glaucoma** (may increase intraocular pressure) and **Prostatic Hypertrophy** (may cause urinary retention). * **Other Antisialogogues:** Atropine and Glycopyrrolate are also used pre-operatively to reduce secretions, with Glycopyrrolate being preferred as it does not cross the blood-brain barrier (less CNS side effects).

Q: Which condition is treated with anticholinesterase drugs?

Alzheimer's disease. **Explanation:** **1. Why Alzheimer’s Disease is Correct:** Alzheimer’s disease is characterized by a deficiency of cholinergic transmission in the brain (specifically in the hippocampus and cortex). **Anticholinesterase drugs** (specifically reversible, centrally acting ones) inhibit the enzyme acetylcholinesterase, thereby increasing the concentration and duration of action of acetylcholine in the synaptic cleft. This helps improve cognitive function and delay symptomatic progression. * **Key Drugs:** Donepezil, Rivastigmine, and Galantamine. **2. Why the Other Options are Incorrect:** * **Multiple Sclerosis (MS):** This is an autoimmune demyelinating disorder of the CNS. Treatment involves disease-modifying therapies (e.g., Interferon-beta, Ocrelizumab) and steroids for acute relapses, not cholinergic enhancement. * **Guillain-Barré Syndrome (GBS):** This is an acute inflammatory demyelinating polyneuropathy (AIDP). Management focuses on supportive care, IVIG, or plasmapheresis. Anticholinesterases have no role here. * **To produce Mydriasis:** Mydriasis (dilation of the pupil) is produced by **Anticholinergics** (e.g., Atropine, Tropicamide) or Sympathomimetics (e.g., Phenylephrine). Anticholinesterases increase acetylcholine, which causes **Miosis** (constriction) by stimulating the sphincter pupillae. **3. High-Yield Clinical Pearls for NEET-PG:** * **Myasthenia Gravis:** The most common clinical use of peripheral anticholinesterases (Pyridostigmine is the drug of choice). * **Edrophonium:** Used in the **Tensilon Test** to differentiate between Myasthenic crisis (improvement) and Cholinergic crisis (worsening). * **Rivastigmine:** Unique among Alzheimer’s drugs as it is available as a **transdermal patch**, reducing GI side effects. * **Glaucoma:** Physostigmine or Echothiophate can be used to reduce intraocular pressure (though rarely first-line today).

Q: Which of the following is the only non-catecholamine sympathomimetic drug?

Ephedrine. ### Explanation The classification of sympathomimetic drugs is based on their chemical structure, specifically the presence or absence of a **catechol nucleus** (a benzene ring with hydroxyl groups at the 3 and 4 positions). **1. Why Ephedrine is the Correct Answer:** **Ephedrine** is a **non-catecholamine**. It lacks the hydroxyl groups on the benzene ring. This structural difference has three major clinical implications: * **Oral Bioavailability:** It is not destroyed by COMT (Catechol-O-methyltransferase), making it effective when taken orally. * **CNS Penetration:** Being more lipid-soluble, it crosses the blood-brain barrier. * **Duration of Action:** It has a significantly longer half-life than catecholamines. Additionally, Ephedrine acts via a **mixed mechanism** (directly stimulating $\alpha$ and $\beta$ receptors and indirectly by displacing norepinephrine from storage vesicles). **2. Why the Other Options are Incorrect:** * **Adrenaline (Epinephrine):** A naturally occurring endogenous catecholamine. It is the drug of choice for anaphylactic shock. * **Dopamine:** An endogenous catecholamine and a precursor to norepinephrine. It acts on D1, $\beta$1, and $\alpha$ receptors in a dose-dependent manner. * **Isoprenaline:** A synthetic catecholamine that acts as a pure $\beta$-agonist ($\beta$1 and $\beta$2). **3. High-Yield NEET-PG Pearls:** * **Tachyphylaxis:** Ephedrine is notorious for causing tachyphylaxis (rapidly diminishing response) with repeated doses due to the depletion of norepinephrine stores. * **Clinical Use:** Ephedrine is frequently used to manage hypotension during spinal anesthesia. * **Mnemonic:** Catecholamines (**D**opamine, **E**pinephrine, **N**orepinephrine, **I**soprenaline, **D**obutamine) = **DENID**. If it’s not on this list, it’s likely a non-catecholamine (e.g., Amphetamine, Phenylephrine, Salbutamol).

Q: Which of the following is NOT associated with beta-2 agonist treatment?

Hyperkalemia. **Explanation:**Beta-2 ($eta_2$) agonists act on G-protein coupled receptors to stimulate various physiological responses. The correct answer is **Hyperkalemia** because $eta_2$ agonists actually cause **hypokalemia**.**1. Why Hyperkalemia is the correct choice (The "NOT" factor):**$eta_2$ receptors stimulate the **Na+/K+ ATPase pump** in skeletal muscles. This causes an influx of potassium from the extracellular fluid into the cells. Consequently, serum potassium levels decrease (**Hypokalemia**). This effect is clinically utilized to treat emergency hyperkalemia (e.g., nebulized Salbutamol) [2].**2. Analysis of Incorrect Options:*** **B. Hyperglycemia:** $eta_2$ stimulation in the liver promotes **glycogenolysis** and **gluconeogenesis**. It also increases glucagon release from the pancreas, leading to elevated blood glucose levels [2].* **C. Detrusor relaxation:** While $eta_3$ receptors are the primary mediators of detrusor relaxation (e.g., Mirabegron), $eta_2$ receptors also contribute to the relaxation of the bladder wall (detrusor muscle), aiding in urine storage.* **D. Relaxation of gut and bronchial muscles:** $eta_2$ agonists cause smooth muscle relaxation via increased cAMP. This leads to **bronchodilation** (the primary use in asthma/COPD) and decreased gastrointestinal motility [1].**High-Yield Clinical Pearls for NEET-PG:** * **Tocolysis:** $eta_2$ agonists like **Ritodrine** and **Terbutaline** are used to relax the uterus and delay premature labor.* **Tremors:** The most common side effect of $eta_2$ agonists is muscle tremors, caused by direct action on $eta_2$ receptors in skeletal muscles.* **Tachycardia:** Even "selective" $eta_2$ agonists can cause tachycardia due to reflex sympathetic stimulation (vasodilation) and minor cross-reactivity with cardiac $eta_1$ receptors.

Q: Which of the following is a selective alpha 2 antagonist?

Yohimbine. **Explanation:** The correct answer is **Yohimbine**. **1. Why Yohimbine is correct:** Yohimbine is a selective **alpha-2 ($\alpha_2$) adrenergic antagonist**. It works by blocking presynaptic $\alpha_2$ receptors, which normally provide negative feedback to inhibit norepinephrine release. By blocking these receptors, yohimbine increases sympathetic outflow. Historically, it was used for erectile dysfunction and orthostatic hypotension, though it is rarely used clinically today due to its side effect profile (tachycardia and hypertension). **2. Analysis of Incorrect Options:** * **A. Prazosin:** This is a highly selective **alpha-1 ($\alpha_1$) antagonist**. It is used clinically for the treatment of hypertension and Benign Prostatic Hyperplasia (BPH). It is notorious for the "first-dose phenomenon" (severe orthostatic hypotension). * **B. Labetalol:** This is a **mixed antagonist** that blocks $\beta_1$, $\beta_2$, and $\alpha_1$ receptors. It is a first-line agent for hypertensive emergencies and pregnancy-induced hypertension (preeclampsia). * **C. Butoxamine:** This is a selective **beta-2 ($\beta_2$) antagonist**. It has no significant clinical utility but is used frequently in pharmacological research to identify $\beta_2$ receptor-mediated effects. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Alpha Blockers:** **P**razosin (**P**rimary $\alpha_1$), **Y**ohimbine (**Y**ields $\alpha_2$ blockade). * **Non-selective Alpha Blockers:** **Phenoxybenzamine** (Irreversible, used in Pheochromocytoma) and **Phentolamine** (Reversible). * **Specific $\alpha_{1A}$ blocker:** **Tamsulosin** is uroselective, used for BPH with minimal effect on blood pressure. * **Idazoxan** is another selective $\alpha_2$ antagonist often mentioned in research contexts alongside Yohimbine.

Question 1

Which of the following beta-blockers possesses intrinsic sympathomimetic properties?

Accepted Answer

Oxprenolol

Answer

Propranolol

Answer

Practolol

Answer

Esmolol

Question 2

All of the following drugs cause mydriasis except?

Accepted Answer

Pilocarpine

Answer

Phenylephrine

Answer

Epinephrine

Answer

Atropine

Question 3

All of the following are selective beta-blockers, except?

Accepted Answer

Celiprolol

Answer

Atenolol

Answer

Esmolol

Answer

Bisoprolol

Question 4

Which of the following is an example of antisialogogues used to control moisture during orthodontic bonding?

Accepted Answer

Banthine

Answer

Epinephrine

Answer

Betamethasone dipropionate

Answer

Paracetamol

Question 5

Which condition is treated with anticholinesterase drugs?

Accepted Answer

Alzheimer's disease

Answer

Multiple sclerosis

Answer

Guillain Barre syndrome

Answer

To produce mydriasis

Question 6

Which of the following is the only non-catecholamine sympathomimetic drug?

Accepted Answer

Ephedrine

Answer

Adrenaline

Answer

Dopamine

Answer

Isoprenaline

Question 7

Acetylcholinesterase inhibitors are not used in which of the following conditions?

Accepted Answer

Carbamate poisoning

Answer

Anticholinergic poisoning

Answer

Cobra bite

Answer

Glaucoma

Question 8

Which of the following is NOT associated with beta-2 agonist treatment?

Accepted Answer

Hyperkalemia

Answer

Hyperglycemia

Answer

Detrusor relaxation

Answer

Relaxation of gut and bronchial muscles

Question 9

Which of the following drugs has the maximum risk of causing dry mouth?

Accepted Answer

Oxybutynin

Answer

Trospium

Answer

Solifenacin

Answer

Flavoxate

Question 10

Which of the following is a selective alpha 2 antagonist?

Accepted Answer

Yohimbine

Answer

Prazosin

Answer

Labetalol

Answer

Butoxamine

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?